Nanoparticles as New Antifungals in the Prevention of Bovine Mycotic Mastitis Caused by Candida spp. and Diutina spp.—In Vitro Studies
Molecules · 2025
DOI: 10.3390/molecules30102086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Magdalena Kot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Animal Breeding Department, Warsaw University of Life Sciences, 02-786 Warsaw, Poland. Hauptthemen laut MEDLINE: Antifungal Agents, Mastitis, Bovine, Metal Nanoparticles, Candida. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bacterial infections are the primary cause of mastitis in dairy cattle. Fungal mastitis occurs in 1–12% of cases. Antibiotic therapy, the standard treatment for mastitis, has led to antibiotic-resistant bacteria, reducing treatment efficacy and increasing fungal mastitis occurrence. Antibiotics lack biocidal effects on fungi, which often exhibit resistance to antifungal agents. This study evaluated the antifungal properties of nanoparticles (NPs) against Candida albicans, Candida glabrata, Candida parapsilosis, Diutina rugosa var. rugosa, Diutina catenulata, and Diutina rugosa. Tested NPs included gold (AuNPs), silver (AgNPs), copper (CuNPs), iron with hydrophilic carbon coating (FeCNPs) (1.56–25 mg/L), and platinum (PtNPs) (0.625–10 mg/L), along with their complexes. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) at 0.75–25 mg/L for AuNPs, AgNPs, CuNPs, and FeCNPs and 0.313–10 mg/L for PtNPs, as well as fungal sensitivity to standard antifungals, were determined. Each strain showed different sensitivities depending on the NPs used and their concentrations. C. glabrata was the most resistant to nanoparticles, while D. catenulata was the most susceptible. PtNPs and FeCNPs showed no or weak biocidal properties. Some mycotic-resistant strains were sensitive to nanoparticles. This study indicates a high in vitro antifungal potential for the application of nanoparticles, especially AgCuNPs, as a new effective non-antibiotic agent for the prevention and control of mycotic mastitis in dairy cattle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Animal Breeding Department, Warsaw University of Life Sciences, 02-786 Warsaw, Poland.
- Department of Nanobiotechnology, Warsaw University of Life Sciences, 02-786 Warsaw, Poland.
- Institute of Optoelectronics, Military University of Technology, gen. S. Kaliskiego 2, 00-908 Warsaw, Poland.
ORCID-Profile: Magdalena Kot, Agata Lange, Weronika Jabłońska, Aleksandra Kalińska, Barbara Nasiłowska, Wojciech Skrzeczanowski, Marcin Gołębiewski
Zitieren
APA
Kot, M., Lange, A., Jabłońska, W., Kalińska, A., Nasiłowska, B., Skrzeczanowski, W., & Gołębiewski, M. (2025). Nanoparticles as New Antifungals in the Prevention of Bovine Mycotic Mastitis Caused by Candida spp. and Diutina spp.—In Vitro Studies. Molecules. https://doi.org/10.3390/molecules30102086
Vancouver
Kot M, Lange A, Jabłońska W, Kalińska A, Nasiłowska B, Skrzeczanowski W, et al. Nanoparticles as New Antifungals in the Prevention of Bovine Mycotic Mastitis Caused by Candida spp. and Diutina spp.—In Vitro Studies. Molecules. 2025. doi:10.3390/molecules30102086
BibTeX
@article{Kot2025,
author = {Kot, Magdalena and Lange, Agata and Jabłońska, Weronika and Kalińska, Aleksandra and Nasiłowska, Barbara and Skrzeczanowski, Wojciech and Gołębiewski, Marcin},
title = {Nanoparticles as New Antifungals in the Prevention of Bovine Mycotic Mastitis Caused by Candida spp. and Diutina spp.—In Vitro Studies},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30102086}
}
EUVIMED